132 related articles for article (PubMed ID: 28633158)
1. [Humoral response markers in GCK MODY].
Skała-Zamorowska E; Deja G; Borowiec M; Fendler W; Małachowska B; Kamińska H; Wyka K; Młynarski W; Jarosz-Chobot P
Pediatr Endocrinol Diabetes Metab; 2016; 22(3):. PubMed ID: 28633158
[TBL] [Abstract][Full Text] [Related]
2. Genetic counseling in monogenic diabetes GCK MODY.
Skała-Zamorowska E; Deja G; Borowiec M; Fendler W; Małachowska B; Kamińska H; Młynarski W; Jarosz-Chobot P
Pediatr Endocrinol Diabetes Metab; 2016; 22(2):54-59. PubMed ID: 28329773
[TBL] [Abstract][Full Text] [Related]
3. HDL cholesterol as a diagnostic tool for clinical differentiation of GCK-MODY from HNF1A-MODY and type 1 diabetes in children and young adults.
Fendler W; Borowiec M; Antosik K; Szadkowska A; Deja G; Jarosz-Chobot P; Mysliwiec M; Wyka K; Pietrzak I; Skupien J; Malecki MT; Mlynarski W
Clin Endocrinol (Oxf); 2011 Sep; 75(3):321-7. PubMed ID: 21521320
[TBL] [Abstract][Full Text] [Related]
4. Phenotype Heterogeneity in Glucokinase-Maturity-Onset Diabetes of the Young (GCK-MODY) Patients.
Wędrychowicz A; Tobór E; Wilk M; Ziółkowska-Ledwith E; Rams A; Wzorek K; Sabal B; Stelmach M; Starzyk JB
J Clin Res Pediatr Endocrinol; 2017 Sep; 9(3):246-252. PubMed ID: 28663157
[TBL] [Abstract][Full Text] [Related]
5. Genetic and clinical characteristics of Chinese children with Glucokinase-maturity-onset diabetes of the young (GCK-MODY).
Li X; Ting TH; Sheng H; Liang CL; Shao Y; Jiang M; Xu A; Lin Y; Liu L
BMC Pediatr; 2018 Mar; 18(1):101. PubMed ID: 29510678
[TBL] [Abstract][Full Text] [Related]
6. Absence of Islet Autoantibodies and Modestly Raised Glucose Values at Diabetes Diagnosis Should Lead to Testing for MODY: Lessons From a 5-Year Pediatric Swedish National Cohort Study.
Carlsson A; Shepherd M; Ellard S; Weedon M; Lernmark Å; Forsander G; Colclough K; Brahimi Q; Valtonen-Andre C; Ivarsson SA; Elding Larsson H; Samuelsson U; Örtqvist E; Groop L; Ludvigsson J; Marcus C; Hattersley AT
Diabetes Care; 2020 Jan; 43(1):82-89. PubMed ID: 31704690
[TBL] [Abstract][Full Text] [Related]
7. An evolving spectrum of diabetes in a woman with GCK-MODY.
Garrahy A; Mijares Zamuner MB; Byrne MM
Endocrinol Diabetes Metab Case Rep; 2019 Jan; 2019():. PubMed ID: 30608898
[TBL] [Abstract][Full Text] [Related]
8. [Clinical, biochemical and immunological characteristic of diabetes type I, LADA, diabetes type II, and MODY patients].
Szepietowska B; Szelachowska M; Górska M; Stepień A; Kinalska I
Pol Arch Med Wewn; 2002 Dec; 108(6):1177-84. PubMed ID: 12687930
[TBL] [Abstract][Full Text] [Related]
9. GCK-MODY in the US National Monogenic Diabetes Registry: frequently misdiagnosed and unnecessarily treated.
Carmody D; Naylor RN; Bell CD; Berry S; Montgomery JT; Tadie EC; Hwang JL; Greeley SA; Philipson LH
Acta Diabetol; 2016 Oct; 53(5):703-8. PubMed ID: 27106716
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic screening of MODY2/GCK mutations in the Norwegian MODY Registry.
Sagen JV; Bjørkhaug L; Molnes J; Raeder H; Grevle L; Søvik O; Molven A; Njølstad PR
Pediatr Diabetes; 2008 Oct; 9(5):442-9. PubMed ID: 18399931
[TBL] [Abstract][Full Text] [Related]
11. Neonatal outcome and diabetes course in children with GCK-MODY born from women with GCK-MODY.
Kopacz-Petranyuk K; Brandt-Varma A; Buraczewska M; Wołoszyn-Durkiewicz A; Peczyńska J; Preis K; Jarosz-Chobot P; Szadkowska A; Młynarski W; Myśliwiec M
Pediatr Endocrinol Diabetes Metab; 2018; 24(4):167-173. PubMed ID: 30963753
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of maturity onset diabetes of the young in a large diabetes center.
Chambers C; Fouts A; Dong F; Colclough K; Wang Z; Batish SD; Jaremko M; Ellard S; Hattersley AT; Klingensmith G; Steck AK
Pediatr Diabetes; 2016 Aug; 17(5):360-7. PubMed ID: 26059258
[TBL] [Abstract][Full Text] [Related]
13. The 0.1% of the population with glucokinase monogenic diabetes can be recognized by clinical characteristics in pregnancy: the Atlantic Diabetes in Pregnancy cohort.
Chakera AJ; Spyer G; Vincent N; Ellard S; Hattersley AT; Dunne FP
Diabetes Care; 2014; 37(5):1230-6. PubMed ID: 24550216
[TBL] [Abstract][Full Text] [Related]
14. The glucokinase mutation p.T206P is common among MODY patients of Jewish Ashkenazi descent.
Gozlan Y; Tenenbaum A; Shalitin S; Lebenthal Y; Oron T; Cohen O; Phillip M; Gat-Yablonski G
Pediatr Diabetes; 2012 Sep; 13(6):e14-21. PubMed ID: 21978167
[TBL] [Abstract][Full Text] [Related]
15. Can Biomarkers Help Target Maturity-Onset Diabetes of the Young Genetic Testing in Antibody-Negative Diabetes?
Majidi S; Fouts A; Pyle L; Chambers C; Armstrong T; Wang Z; Batish SD; Klingensmith G; Steck AK
Diabetes Technol Ther; 2018 Feb; 20(2):106-112. PubMed ID: 29355436
[TBL] [Abstract][Full Text] [Related]
16. Identification of monogenic variants in more than ten per cent of children without type 1 diabetes-related autoantibodies at diagnosis in the Finnish Pediatric Diabetes Register.
Harsunen M; Kettunen JLT; Härkönen T; Dwivedi O; Lehtovirta M; Vähäsalo P; Veijola R; Ilonen J; Miettinen PJ; Knip M; Tuomi T
Diabetologia; 2023 Mar; 66(3):438-449. PubMed ID: 36418577
[TBL] [Abstract][Full Text] [Related]
17. Should the negativity for islet cell autoantibodies be used in a prescreening for genetic testing in maturity-onset diabetes of the young? The case of autoimmunity-associated destruction of pancreatic β-cells in a family of HNF1A-MODY subjects.
Urbanová J; Rypáčková B; Kučera P; Anděl M; Heneberg P
Int Arch Allergy Immunol; 2013; 161(3):279-84. PubMed ID: 23548576
[TBL] [Abstract][Full Text] [Related]
18. Identification of Novel
Katashima R; Matsumoto M; Watanabe Y; Moritani M; Yokota I
J Diabetes Res; 2021; 2021():7216339. PubMed ID: 34746319
[TBL] [Abstract][Full Text] [Related]
19. Towards a systematic nationwide screening strategy for MODY.
Shields B; Colclough K
Diabetologia; 2017 Apr; 60(4):609-612. PubMed ID: 28132100
[TBL] [Abstract][Full Text] [Related]
20. Molecular Diagnosis of Monogenic Diabetes and Their Clinical/Laboratory Features in Turkish Children.
Gökşen D; Yeşilkaya E; Özen S; Kor Y; Eren E; Korkmaz Ö; Berberoğlu M; Karagüzel G; Er E; Abacı A; Evliyaoğlu O; Akbaş ED; Ünal E; Bolu S; Nalbantoğlu Ö; Anık A; Tayfun M; Büyükinan M; Abalı S; Can Yılmaz G; Kor D; Söbü E; Şıklar Z; Polat R; Darcan Ş
J Clin Res Pediatr Endocrinol; 2021 Nov; 13(4):433-438. PubMed ID: 34250910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
